BUZZ-Hims & Hers Health falls; JP Morgan Chase cuts stake in co
Reuters
Mar 06
BUZZ-Hims & Hers Health falls; JP Morgan Chase cuts stake in co
** Shares of teleheath firm Hims & Hers Health HIMS.N fall 3.8% to $15.83
** Wall Street titan JPMorgan Chase JPM.N has cut its stake in HIMS from 8.1% to 1.7%, a regulatory filing showed as of February 27
** Hims has faced a wave of controversies in recent weeks after announcing and quickly withdrawing a $49 compounded version of Novo Nordisk’s NOVOb.CO weight‑loss drug Wegovy, following legal threats and regulatory scrutiny
** The company when reporting earnings said it would be facing a $65 million burden in the first quarter from changes in the shipping of weight-loss products, which must be personalized for each prescription based on U.S. law
** Including session's move, HIMS stock has halved YTD
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com))
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.